Table of Contents Table of Contents
Previous Page  317 / 812 Next Page
Information
Show Menu
Previous Page 317 / 812 Next Page
Page Background

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348

S313

obsessive dimensionmight have a pathoplastic influence, balancing

the effect of low disorganization symptoms.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.678

EW561

Analysis of the attitudes towards the

medication in ambulatory patients

with diagnosis of schizophrenia

E. Torío

, L. G

onzález Blanco , I. Abad Acebedo ,

S. Bestene Medina , J. Rodriguez Revuleta

Hospital Universitario Central de Asturias, Psiquiatría, Oviedo, Spain

Corresponding author.

Introduction

The scale autoappliedDrug Attitude Inventory (DAI)

[1] is

an instrument to evaluate the subjective response to the neu-

roleptics in patients diagnosed of schizophrenia. We have used the

brief version

[2] .

Objectives

To study the possible relation between DAI and

sociodemographic factors [3] as well as medical treatment [4] (ref-

erences 3 and 4 are not available for this abstract).

Methods

A descriptive and comparative study. Sample of 30

patients with ambulatory follow-up from Oviedo. Sociodemo-

graphic data and drug prescription were collected.

Results

Comparative analysis: DAI and sociodemographic, drug

prescription

( Table 1 ).

Correlation between DAI/age/I number of

antipsychotics

( Table 2 ).

The comparative analysis only shows

positive significant correlation between DAI and antidepressant

treatment.

Conclusions

There is no correlation of DAI depending on the age

and the number of antipsychotics. The antidepressant treatment

in schizophrenic patients could be a predictor variable of better

punctuation in DAI.

Table 1

DAI mean

±

SD

Statistics

Sex: man/woman

16.21

±

2.07/16.54

±

0.93

t

= 0.50

5 a

Age: <45/

45

16.77

±

1.56/16.10

±

1.83

t

= –0.96

1 a

Polytheraphy

16.38

±

1.83

t

= 0.40

8 a

Antipsychotic:

typical/atypical

14.50

±

0.70/16.46

±

1.71

t

= –1.59

3 a

Depot + oral

16.12

±

1.96

t

= –0.69

9 a

Antypsichotic

depot

16.25

±

1.88

t

= –0.36

8 a

BZD

16.46

±

1.59

t

= 0.41

6 a

Antidepressants

yes/antidepressants

no

17.37

±

1.06/15.95

±

1.78

t

= 2.10

5 b

Anticovulsants/

anticholinergics

16.37

±

1.40/15.83

±

2.13

t

= 0.07

8 a /

t

= –0.78

7 a

SD = Standard deviation.

a

P

0.05,not significant.

b

P

< 0.05,significant.

Table 2

DAI (Correlation

Pearson)

DAI (significant)

Age

–0.05

0.79

7 a

No. of antypsichotics –0.07

0.70

0 a

a

P

0.05, not significant.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

References

[1] Hogan TP, Awad AG, EastwoodMR. A self-report scale predictive

of drug compliance in schizophrenia: reliability and discrimi-

nate validity. Psychol Med 1983:177–83.

[2] García-Portilla, et al. Banco de instrumentos básicos para la

práctica de la psiquiatría clínica. Barcelona: ARS MEDICA; 2008.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.679

EW562

Affective psychopathology and

recognition of facial expressions in

schizophrenia and in affective

disorders

S. Trifu

1 ,

, L. Radoi

2

1

UMF Carol Davila, Psychiatry, Bucharest, Romania

2

University of Bucharest, Psychology, Bucharest, Romania

Corresponding author.

Introduction

We noticed some differences between the patients

diagnosed with schizophrenia, those diagnosed with affective dis-

orders and the normal persons, as regards the empathy level, the

recognition degree of facial expressions, depression level of posi-

tive/negative affectivity.

Objectives

The exploration of its affectivity and pathology, aswell

as the changes emerging in the forming of interpersonal relation-

ships with others in schizophrenia and in affective disorders, and

the comparison of these changes with the values recorded within

the group of normal persons.

Aims

Highlighting some differences as regards aspects of affec-

tive life and forming of interpersonal relationships in patients

diagnosed with schizophrenia/affective disorder.

Methods

The instruments used: Beck’s Depression Inventory

(BDI), Toronto Empathy Questionnaire (TEQ), The Positive and Neg-

ative Affect Schedule (PANAS) and a test of identification of facial

expressions.

Results

Empathy level in close relation to type of psychiatric dis-

order (

F

= 26.84,

P

< 0.001). Depression level in relation with type of

psychic disorder (

P

< 0.001). There is a relation between the positive

affectivity and the psychiatric diagnosis of schizophrenia, affective

disorder or the absence of the diagnosis (

F

= 9.15,

P

< 0.001). The

level of negative affectivity is in relation with the psychiatric diag-

nosis (

F

=4.83,

P

= 0.011). Capacity of recognition of facial expression

in relation with psychiatric diagnosis (

P

< 0.001).

Conclusions

The conclusions of the research highlight the

changes emerging at the level of affectivity in pathology, as well

as the effects these changes have over the patient’s contact with

his/her own emotions and with the emotions of those around.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.680

EW563

Evolution of schizophrenia under

treatment with atypical versus

conventional antipsychotic

S. Trifu

1 ,

, A. Badea

2

1

UMF Carol Davila, Psychiatry, Bucharest, Romania

2

University of Bucharest, Psychology, Bucharest, Romania

Corresponding author.

Introduction

Over the time, schizophrenia experienced vari-

ous phases of the treatment methods, at the beginning dealing

with simple tranquillizers, more disagreeable methods follow-

ing, some of them even controversial. Finally, medical progresses